EMA – Fifth EMA/HMA Big Data Stakeholder Forum – Online: 28 November 2024

As the journey towards data-driven medicines regulation continues, a new phase for the regulatory network is starting. The value of real-world data for evidence generation is becoming more established and technological advances, e.g. in the area of artificial intelligence (AI), have occurred more rapidly than originally anticipated. At the same time, the EU Network is accelerating its efforts to strengthen data governance, to share more data across the Network and to foster high level of data interoperability and standardization.

The fifth annual Big Data multi-stakeholder forum will take place on 28 November 2024 at the EMA building in Amsterdam.

It aims to:

• Inspire with keynotes speakers;
• Discuss progress on evidence generation, interoperability, use and exchange of medicines data across the EU network, to support regulatory decision-making and improve medicines development and the EU;
• Inform the fifth update of the HMA-EMA Big Data Steering Group workplan and therefore strengthen collaboration with stakeholders and partners on the delivery of the data activities included the Network Strategy.

More information on this event on the EMA Website.